Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade ...
In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback